Intelligence ยท Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors โ phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ searchable for business development and competitive intelligence.
-
Cy-TB test
International Peace Maternity and Child Health Hospital
Latent Tuberculosis
1 trial -
Cyclophosphamide
Ultragenyx UK Limited
Systemic Lupus Erythematosus
1 trial -
Cyclosporin A
The First People's Hospital of Lianyungang
Acute Leukemia
1 trial -
Cytoxan
shifeng Lou
Hemophagocytic Syndrome
1 trial -
D-Galactose
United Therapeutics Europe Ltd
Focal Segmental Glomerulosclerosis
1 trial -
DAOSiNยฎ/ Placebo & ProvokAminยฎ Ingestion
Century Therapeutics
Histamine Intolerance
1 trial -
DC-TC+GM-CSF
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary Hepatocellular Carcinoma
1 trial -
DGB-01 Supplementation
Blackmores Limited
Fatigue
1 trial -
DHA-piperaquine
United Therapeutics Europe Ltd
Malaria
1 trial -
DM199
DiaMedica Therapeutics
Pre-Eclampsia
1 trial -
DPP4
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus
1 trial -
Da Jian Zhong Tang (Zanthoxylum, Ginger, Ginseng, Maltose)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ERAS
1 trial -
Dairy based toddler nutrition
United Therapeutics Europe Ltd
Weight Gain
1 trial -
Dapagliflozin
Hospital Authority, Hong Kong
Diabetes Mellitus, Type 2
1 trial -
Dapagliflozin Treatment Group
The First People's Hospital of Lianyungang
Atrial Fibrillation (AF)
1 trial -
Daphne Extract Capsules
The First People's Hospital of Lianyungang
Epithelial Ovarian Cancer
1 trial -
Daratumumab
The First People's Hospital of Lianyungang
Antibody-mediated Rejection
1 trial -
Dasatinib
The First People's Hospital of Lianyungang
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1 trial -
Dentoblis
The First People's Hospital of Lianyungang
Gingivitis; Chronic
2 trials -
Depot Naltrexone
BRIGHT MINDS BIOSCIENCES INC.
Opioid Dependence
1 trial -
Desflurane
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Delirium
1 trial -
Deucravacitinib
The First People's Hospital of Lianyungang
Palmoplantar Pustulosis
1 trial -
Device measurements
COGNITION THERAPEUTICS INC
Healthy
1 trial -
Device measurements during overnight sleep and morning wake
COGNITION THERAPEUTICS INC
Healthy
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1โ3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources